Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4.

Zekri, A R N; Haleem, H A; Esmat, G E-D; Bahnassy, A A; El-Din, H M A; Hafez, M M; Sharaby, A F; Sharaf, H; Zakaria, M S E-D

Zekri, A R N; Haleem, H A; Esmat, G E-D; Bahnassy, A A; El-Din, H M A; Hafez, M M; Sharaby, A F; Sharaf, H; Zakaria, M S E-D.

Affiliation

Zekri AR; Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt. ncizakri@starnet.com.eg

J Viral Hepat ; 14(7): 468-77, 2007 Jul.

Article in En | MEDLINE | ID: mdl-17576388

Subject(s)

Antiviral Agents/therapeutic use; Fas Ligand Protein/blood; Hepatitis C, Chronic/drug therapy; Interferon-alpha/therapeutic use; fas Receptor/blood; Adult; Cytokines/blood; Drug Therapy, Combination; Female; Genotype; Hepacivirus/classification; Hepacivirus/drug effects; Hepacivirus/genetics; Hepatitis C, Chronic/immunology; Hepatitis C, Chronic/virology; Humans; Interferon alpha-2; Male; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Receptors, Tumor Necrosis Factor, Type II/blood; Recombinant Proteins; Ribavirin/therapeutic use; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Interferon-alpha / Fas Receptor / Hepatitis C, Chronic / Fas Ligand Protein Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Viral Hepat Journal subject: GASTROENTEROLOGIA Year: 2007 Document type: Article Affiliation country: Egypt

Search on Google

Add to My VHL

XML

PubMed Links